Otoprotective and antioxidant activity of cytoflavin in pulmonary tuberculosis patients receiving amikacin
The objective: to study the potential otoprotective and antioxidant activity of cytoflavin in new pulmonary tuberculosis patients receiving aminoglycoside amikacin.Subjects and Methods. A randomized controlled trial was conducted and included 90 patients with new infiltrative pulmonary tuberculosis...
Saved in:
| Main Authors: | A. A. Solokha, N. V. Tursunova, N. V. Stavitskaya, A. V. Voronov, Ya. Sh. Schvartz |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
New Terra Publishing House
2023-10-01
|
| Series: | Туберкулез и болезни лёгких |
| Subjects: | |
| Online Access: | https://www.tibl-journal.com/jour/article/view/1755 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of Methionine and Glutathione on Acute Ototoxicity Induced by Amikacin and Furosemide in an Animal Model of Hearing Threshold Decrease
by: Marek Zadrożniak, et al.
Published: (2025-06-01) -
Current Methods of Prevention of Aminoglycoside Ototoxicity in Patients with Pulmonary Tuberculosis
by: A. A. Solokha, et al.
Published: (2023-07-01) -
Aminoglycoside-induced hearing deficits – a review of cochlear ototoxicity
by: Lucretia Petersen, et al.
Published: (2015-04-01) -
Comparison of clinical outcomes of treatment with cefepime monotherapy vs. amikacin-ceftriaxone combination in children with chemotherapy-induced fever and neutropenia
by: Zahra Ghelichkhan, et al.
Published: (2025-04-01) -
Amikacin-loaded selenium nanoparticles improved antibacterial and antibiofilm activity of amikacin against bovine mastitis-causing Staphylococcus aureus
by: Leila Asadpour, et al.
Published: (2025-01-01)